(Q73135687)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

fluticasone propionate

1 reference

J H Heinig

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

L P Boulet

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

L Croonenborghs

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M J Möllers

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

613-620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

Importance of the inhalation device on the effect of budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

Assessing equivalence of inhaled drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

General factors influencing drug delivery to the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler (P-MDI)

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990100-2

7 January 2021

10.1016/S0954-6111(99)90100-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10542974%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference